Clinical Trials
Study Title:
A Phase 1/2 Dose Escalation and Dose Expansion Study of Ozuriftamab Vedotin (BA3021) Alone and in Combination With Nivolumab In Patients With Advanced Solid Tumors
|
For more information about the trial above please contact the study team:
|